E*Trade Securities, the institutional division of E*Trade Group, the electronic brokerage, has expanded its independent equity research team with the appointment of Michael Leacock as European pharmaceutical analyst.

Leacock joins E*Trade Securities from Credit Lyonnais, where he integrated its UK and Northern European pharmaceutical research into a pan-European product.